Animals and AI are exhibiting behaviours that blur the lines of instinct, intelligence, and awareness. New scientific models, like a five-dimension fr ...

The firm's new strategy revolves around adding to its test menu in an impactful way and expanding its installed base of instruments.

Roughly 1 in 3 adults has metabolic dysfunction–associated steatotic liver disease, or MASLD. A doctor outlines how to detect ...

Recognizing early liver disease signs is crucial as many conditions develop silently. Persistent fatigue, jaundice, abdominal swelling, confusion, fre ...

Jefferies London Healthcare Conference 2025 November 20, 2025 3:00 AM ESTCompany ParticipantsVipin Garg - President, CEO ...

ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in biomarker imaging technologies for the early ...

Molecular profiles will give detailed snapshot of person’s physiology and predict diseases from diabetes to cancer and dementia ...

Managing diabetes with injections is challenging. Joining insulin to a skin-penetrating polymer was as effective as shots at regulating blood sugar.

Baystreet.ca News Commentary – The metabolic disorder therapeutics market projects growth to $120.7 billion by 2030 as biotechnology firms pioneer organ-level treatments addressing ...

Liver fibrosis is a growing global concern, driven by chronic conditions like hepatitis, obesity, and alcohol use. This progressive liver disease, marked by scar tissue buildup, can advance to ...

With obesity and diabetes rates soaring in South Africa, fatty liver disease has emerged as a pressing public health issue.

Even newer “minimally invasive” ideas, like stent-mounted electrodes deployed through blood vessels, still require a catheter ...